Nakamura J, Seki N, Sasaki H, Shibasaki J
Faculty of Pharmaceutical Sciences, Nagasaki University, Japan.
J Pharmacobiodyn. 1988 Sep;11(9):620-4. doi: 10.1248/bpb1978.11.620.
The effect of oral pretreatment with indomethacin on the intestinal first-pass metabolism of salicylamide (SAM) was studied in rabbits using in situ intestinal sacs with complete mesenteric venous blood collection. The appearance of both SAM and its metabolites into the mesenteric venous blood was measured directly by cannulating the mesenteric vein of exposed rabbit intestine and collecting all venous blood draining from the absorbing region. By oral pretreatment with indomethacin, the total amounts of SAM absorbed in 20 and 120 min were significantly increased compared to the control. These results indicated the alteration of the permeability in the intestinal mucosa. In 20 min, indomethacin pretreatment resulted in increased appearance of SAM and SAM glucuronide in the mesenteric venous blood. In 120 min, increased appearance of SAM and decreased appearance of SAM sulfate were observed, compared to the control. These findings suggested that the change in the intestinal first-pass metabolism of SAM is probably due to the intestinal mucosal damage by oral pretreatment with indomethacin.
在兔子身上,采用带有完整肠系膜静脉血采集的原位肠囊,研究了吲哚美辛口服预处理对水杨酰胺(SAM)肠道首过代谢的影响。通过插管暴露的兔肠肠系膜静脉并收集从吸收区域流出的所有静脉血,直接测定SAM及其代谢产物进入肠系膜静脉血的情况。与对照组相比,通过吲哚美辛口服预处理,20分钟和120分钟时吸收的SAM总量显著增加。这些结果表明肠黏膜通透性发生了改变。在20分钟时,吲哚美辛预处理导致肠系膜静脉血中SAM和SAM葡萄糖醛酸苷的出现增加。与对照组相比,在120分钟时,观察到SAM的出现增加,而SAM硫酸盐的出现减少。这些发现表明,SAM肠道首过代谢的变化可能是由于吲哚美辛口服预处理对肠黏膜造成的损伤。